P

ProQR Therapeutics NV
D

PRQR

1.92000
USD
0.11
(6.08%)
مغلق
حجم التداول
25,064
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
270,953,234
أصول ذات صلة المقالات
المزيد

العنوان: ProQR Therapeutics NV

القطاع: الرعاية الصحية
الصناعة: Biotechnology
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.